Debrichem® offers a very effective, alternative approach to chronic wound care, initiating healing in more…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a collaboration agreement has been signed…
Positive Phase 2 results with pMDI ensifentrine in COPD Enrollment ongoing in ENHANCE Phase 3…
JANUARY – DECEMBER 2020 Net sales amounted to MSEK 0.3 (0.0) Operating expenses amounted to…
Excellent progress on clinical programs Unprecedented partnering deal signed with Pfizer for Lyme disease vaccine…
February 25, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company…
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these…
Initiation of Mechanistic Study of TTP399 expected during Q1 2021 Announcement of First-Patient First-Visit in…
EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE)…
ERYTECH to Participate in Upcoming Virtual Investor Conferences in March Lyon (France) and Cambridge, MA…
-Broad advancement of clinical pipeline- -Three-arm Phase 2 study of praluzatamab ravtansine (CX-2009) launched in…
– Data demonstrate that ImmTOR has the potential to enhance transgene expression in the liver…
Achieved Oxbryta® (voxelotor) net revenues of $41.3 million in the fourth quarter and $123.8 million for…
Fourth Quarter Highlights: Consolidated Net Revenue of $13.8 Million Up 10% vs. Third Quarter of…
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
JERSEY, Channel Islands, Feb. 24, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
– G1’s COSELA™ (trilaciclib) Approved by FDA as First and Only Therapy to Decrease the…
— NUZYRA Generated Net U.S. Sales of $12.4 Million in the Fourth Quarter 2020; a…